copper peptide ghk cu hair growth clinical trial randomized (2016) — Research Summary Thermodynamically stable ionic liquid microemulsions

The incidence of these effects appears low based on community reports, with the majority of users experiencing no notable adverse effects during standard protocol use

Clinical trials in retinitis pigmentosa showed 90% patient improvement with increased visual acuity and expanded visual field borders

Care must be exercised when containerclosure changes are considered

GHK-Cu injections aren't affected by food timing, so inject whenever is convenient

The most commonly reported side effects in clinical trials include: Nausea Vomiting Diarrhea Constipation Most of these symptoms were mild to moderate and tended to improve over time as the body adjusted to the medication, especially when doses were increased gradually